Similar articles

• Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.

  Biggio G, Costa E, Guidotti A. Biggio G, et al. J Pharmacol Exp Ther. 1977 Jan;200(1):207-15. J Pharmacol Exp Ther. 1977. PMID: 13199
• Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.

  Biggio G, Corda MG, Casu M, Gessa GL. Biggio G, et al. Adv Biochem Psychopharmacol. 1978;18:227-44. Adv Biochem Psychopharmacol. 1978. PMID: 206110 Review. No abstract available.
• Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.

  Costa E, Guidotti A, Mao CC. Costa E, et al. Adv Biochem Psychopharmacol. 1975;(14):113-30. Adv Biochem Psychopharmacol. 1975. PMID: 242198 Review. No abstract available.
• Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.

  Burkard WP, Pieri L, Haefely W. Burkard WP, et al. Adv Biochem Psychopharmacol. 1976;15:315-24. Adv Biochem Psychopharmacol. 1976. PMID: 192051
• Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action diazepam.

  Mao CC, Guidotti A, Costa E. Mao CC, et al. Naunyn Schmiedebergs Arch Pharmacol. 1975;289(4):369-78. doi: 10.1007/BF00508411. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 240134